Alto Neuroscience Inc
ANRO3.065USD
+0.015+0.49%
交易中 （美東）報價延遲15分鐘
82.98M總市值
虧損本益比TTM
關於 Alto Neuroscience Inc 公司
Alto Neuroscience, Inc. 是一家臨牀階段的生物製藥公司。該公司專注於通過利用個人的神經生物學來開發個性化和有效的治療方案，從而重新定義精神病學。通過從該公司可擴展且專有的精準精神病學平臺獲得的見解，該平臺將嚴格的數據科學和強大的分析應用於神經認知評估、腦電圖和可穿戴設備收集的數據，該公司旨在發現基於大腦的生物標記，以更好地確定哪些患者更有可能對其新產品候選物產生反應。其產品線由五種臨牀階段資產組成，例如 ALTO-100、ALTO-202、ALTO-300、ALTO-101 和 ALTO-203，針對由獨立基於大腦的生物標記物確定的抑鬱症和精神分裂症人羣。其產品線還包括抑鬱症、創傷後應激障礙 (PTSD) 和其他精神健康狀況的新型候選藥物。
公司簡介
公司代碼ANRO
公司名稱Alto Neuroscience Inc
上市日期Feb 02, 2024
CEODr. Amit Etkin, M.D., Ph.D.
員工數量76
證券類型Ordinary Share
年結日Feb 02
公司地址650 Castro Street, Suite 450
城市MOUNTAIN VIEW
上市交易所NYSE Consolidated
國家United States of America
郵編94041
電話17732555012
網址https://www.altoneuroscience.com/
公司代碼ANRO
上市日期Feb 02, 2024
CEODr. Amit Etkin, M.D., Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Amit Etkin, M.D., Ph.D.
Dr. Amit Etkin, M.D., Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.21M
--
Mr. Christopher Nixon (Chris) Cox
Mr. Christopher Nixon (Chris) Cox
Independent Director
Independent Director
715.65K
--
Mr. Adam Savitz, M.D., Ph.D.
Mr. Adam Savitz, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
24.85K
+216.53%
Dr. Husseini Manji, M.D.
Dr. Husseini Manji, M.D.
Director
Director
--
--
Mr. Andrew Dreyfus
Mr. Andrew Dreyfus
Independent Director
Independent Director
--
--
Ms. Gwill York
Ms. Gwill York
Independent Director
Independent Director
--
--
Mr. Nicholas (Nick) Smith
Mr. Nicholas (Nick) Smith
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Michael Hanley
Mr. Michael Hanley
Chief Operating Officer
Chief Operating Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Amit Etkin, M.D., Ph.D.
Dr. Amit Etkin, M.D., Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.21M
--
Mr. Christopher Nixon (Chris) Cox
Mr. Christopher Nixon (Chris) Cox
Independent Director
Independent Director
715.65K
--
Mr. Adam Savitz, M.D., Ph.D.
Mr. Adam Savitz, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
24.85K
+216.53%
Dr. Husseini Manji, M.D.
Dr. Husseini Manji, M.D.
Director
Director
--
--
Mr. Andrew Dreyfus
Mr. Andrew Dreyfus
Independent Director
Independent Director
--
--
Ms. Gwill York
Ms. Gwill York
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Alpha Wave Global, LP
13.70%
Armistice Capital LLC
5.91%
BlackRock Institutional Trust Company, N.A.
4.98%
Fidelity Management & Research Company LLC
4.70%
Point72 Asset Management, L.P.
4.58%
Other
66.14%
持股股東
持股股東
佔比
Alpha Wave Global, LP
13.70%
Armistice Capital LLC
5.91%
BlackRock Institutional Trust Company, N.A.
4.98%
Fidelity Management & Research Company LLC
4.70%
Point72 Asset Management, L.P.
4.58%
Other
66.14%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
23.92%
Investment Advisor
21.68%
Hedge Fund
16.21%
Venture Capital
13.81%
Individual Investor
7.48%
Private Equity
0.92%
Research Firm
0.54%
Family Office
0.24%
Bank and Trust
0.14%
Other
15.06%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
172
22.95M
84.79%
-8.11M
2025Q1
171
24.58M
90.79%
-9.93M
2024Q4
154
26.22M
97.22%
-2.96M
2024Q3
131
26.77M
99.31%
+3.33M
2024Q2
102
22.89M
85.38%
+1.53M
2024Q1
71
21.11M
78.78%
+8.14M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Alpha Wave Global, LP
3.71M
13.7%
--
--
Mar 31, 2025
Armistice Capital LLC
1.60M
5.91%
+950.00K
+146.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.35M
4.98%
-21.19K
-1.55%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.27M
4.7%
+7.14K
+0.56%
Mar 31, 2025
Point72 Asset Management, L.P.
1.24M
4.58%
-452.10K
-26.72%
Mar 31, 2025
The Vanguard Group, Inc.
1.22M
4.5%
-11.02K
-0.90%
Mar 31, 2025
Etkin (Amit)
1.21M
4.45%
--
--
Mar 17, 2025
Franklin Advisers, Inc.
1.16M
4.29%
--
--
Mar 31, 2025
Vestal Point Capital, LP
915.00K
3.38%
--
--
Mar 31, 2025
AWM Investment Company, Inc.
901.98K
3.33%
+214.15K
+31.13%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 ETF
0%
ALPS Medical Breakthroughs ETF
0%
Schwab U.S. Small-Cap ETF
0%
Schwab U.S. Broad Market ETF
0%
ProShares Hedge Replication ETF
0%
iShares Neuroscience and Healthcare ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
iShares Micro-Cap ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
ALPS Medical Breakthroughs ETF
佔比0%
Schwab U.S. Small-Cap ETF
佔比0%
Schwab U.S. Broad Market ETF
佔比0%
ProShares Hedge Replication ETF
佔比0%
iShares Neuroscience and Healthcare ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
